alovudine has been researched along with Colorectal Neoplasms in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (26.09) | 29.6817 |
2010's | 17 (73.91) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jinguji, M; Kajiya, Y; Kitazono, M; Nakajo, M; Tani, A; Yoshiura, T | 1 |
Aboagye, EO; Doblas, S; Döring, C; Faber, C; Fricke, IB; Griffiths, JR; Heinzmann, K; Heller, A; Hermann, S; Honess, DJ; Jacobs, AH; Just, N; Rieder, N; Schäfers, KP; Schelhaas, S; Schneider, R; Sinkus, R; Smith, DM; Wachsmuth, L | 1 |
Jiang, HJ; Li, M; Li, X; Pan, WB; Wang, YQ; Xu, HL; Zhang, MY; Zhang, RJ | 1 |
Chen, Y; Liu, B; Qu, B; Tian, J; Wang, H; Xu, B; Zhang, J | 1 |
Aridome, K; Fukukura, Y; Jinguji, M; Kajiya, Y; Koriyama, C; Nakajo, M; Nihara, T; Nishimata, N; Shimaoka, S; Tanaka, S; Tani, A | 1 |
Hong, YS; Kim, HJ; Kim, HO; Kim, JS; Kim, KP; Kim, TW; Lee, JL; Lee, SJ; Moon, DH; Oh, SJ; Ryu, JS | 1 |
Binns, D; Bogatyreva, E; Bradley, DP; Cullinane, C; de Jong, R; Hicks, RJ; McArthur, GA; Waldeck, KL | 1 |
Haagensen, EJ; Harnor, SJ; Maxwell, RJ; Newell, DR; Payne, SL; Rennison, T; Smith, KM; Thomas, HD; Wilson, I | 1 |
Fukukura, Y; Goto, Y; Higashi, M; Jinguji, M; Kajiya, Y; Nakajo, M; Tanaka, S; Tani, A | 1 |
Buck, JR; Cheung, YY; Manning, HC; McKinley, ET; Nickels, ML | 1 |
Barjat, H; Emmas, SA; Honndorf, VS; Pichler, BJ; Quintanilla-Martinez, L; Schmidt, H; Stahlschmidt, A; Wehrl, HF; Wiehr, S | 1 |
Pauwels, P; Rapic, S; Staelens, S; Stroobants, S; Thomae, D; Van den Wyngaert, T; Vangestel, C; Verhaeghe, J | 1 |
De Weer, S; Debucquoy, A; Devos, E; Haustermans, K; Landuyt, W; Van Den Heuvel, F; Vermaelen, P | 1 |
Asakura, M; Haba, R; Hagiike, M; Izuishi, K; Kameyama, R; Nishiyama, Y; Takebayashi, R; Yamamoto, Y | 1 |
Chen, Y; Li, T; Liu, J; Qu, B; Tian, J; Wang, H; Wang, S; Zhang, J | 1 |
Aboagye, EO; Al-Nahhas, A; Contractor, KB; Coombes, RC; Gray, KR; Kenny, LM; Rosso, L; Shousha, S; Stebbing, J; Turkheimer, FE; Wasan, HS | 1 |
Bukofzer, G; Chakravartty, A; Cole, TB; Day, M; Donawho, CK; Fox, GB; Holich, KD; Luo, Y; Mudd, SR; Palma, JP; Reuter, DR; Tapang, P; Voorbach, MJ | 1 |
Aboagye, E; Al-Nahhas, A; Challapalli, A; Contractor, K; Coombes, RC; Kenny, L; Mangar, S; Palmieri, C; Riddle, P; Rosso, L; Sharma, R; Stebbing, J; Tomasi, G; Turkheimer, F; Wasan, H | 1 |
Kjaer, A; Madsen, J; Persson, M; Ploug, M; Rasmussen, P | 1 |
Coffey, RJ; Fu, A; Manning, HC; McKinley, ET; Saleh, SA; Smith, RA; Uddin, MI; Washington, MK; Zhao, P | 1 |
Arulampalam, TH; Costa, DC; Ell, PJ; Francis, DL; Luthra, SK; Taylor, I; Townsend, C; Visvikis, D | 1 |
Arulampalam, TH; Costa, DC; Croasdale, I; Ell, PJ; Francis, DL; Luthra, SK; Taylor, I; Visvikis, D | 1 |
Costa, DC; Croasdale, I; Ell, PJ; Francis, D; Luthra, SK; Mulligan, R; Taylor, I; Visvikis, D | 1 |
5 trial(s) available for alovudine and Colorectal Neoplasms
Article | Year |
---|---|
3'-Deoxy-3'-18F-fluorothymidine PET for the early prediction of response to leucovorin, 5-fluorouracil, and oxaliplatin therapy in patients with metastatic colorectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Dideoxynucleosides; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Positron-Emission Tomography; Survival Analysis; Time Factors; Treatment Outcome | 2013 |
Detection of colorectal cancer using ¹⁸F-FLT PET: comparison with ¹⁸F-FDG PET.
Topics: Adult; Aged; Aged, 80 and over; Cell Proliferation; Colorectal Neoplasms; Dideoxynucleosides; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies | 2009 |
Imaging of cellular proliferation in liver metastasis by [18F]fluorothymidine positron emission tomography: effect of therapy.
Topics: Aged; Breast Neoplasms; Cell Proliferation; Colorectal Neoplasms; Dideoxynucleosides; Female; Humans; Liver Neoplasms; Male; Middle Aged; Positron-Emission Tomography; Treatment Outcome | 2012 |
Potential impact of [18F]3'-deoxy-3'-fluorothymidine versus [18F]fluoro-2-deoxy-D-glucose in positron emission tomography for colorectal cancer.
Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Whole-Body Counting | 2003 |
Comparison of methodologies for the in vivo assessment of 18FLT utilisation in colorectal cancer.
Topics: Aged; Aged, 80 and over; Colorectal Neoplasms; Dideoxynucleosides; Female; Humans; Image Interpretation, Computer-Assisted; Male; Metabolic Clearance Rate; Middle Aged; Organ Specificity; Radiography; Radioisotope Dilution Technique; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Whole-Body Counting | 2004 |
18 other study(ies) available for alovudine and Colorectal Neoplasms
Article | Year |
---|---|
A pilot study for texture analysis of
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Pilot Projects; Positron Emission Tomography Computed Tomography; Prognosis; Recurrence; Retrospective Studies; Survival Analysis | 2017 |
Thymidine Metabolism as a Confounding Factor for 3'-Deoxy-3'-
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Artifacts; Biological Transport; Cell Transformation, Neoplastic; Colorectal Neoplasms; Dideoxynucleosides; Diffusion Magnetic Resonance Imaging; Female; Fluorouracil; HCT116 Cells; Humans; Leucovorin; Mice; Organoplatinum Compounds; Thymidine | 2018 |
Prediction of tumor biological characteristics in different colorectal cancer liver metastasis animal models using
Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Colorectal Neoplasms; Dideoxynucleosides; Feasibility Studies; Fluorodeoxyglucose F18; Humans; Hyaluronan Receptors; Immunohistochemistry; Ki-67 Antigen; Linear Models; Liver Neoplasms; Mice, Nude; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Time Factors; Vascular Endothelial Growth Factor A | 2018 |
Evaluation of ¹⁸F-FDG and ¹⁸F-FLT for monitoring therapeutic responses of colorectal cancer cells to radiotherapy.
Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Dideoxynucleosides; Dose-Response Relationship, Radiation; Fluorodeoxyglucose F18; Humans; Metabolic Clearance Rate; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy, Image-Guided; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2013 |
Diagnostic performance of ¹⁸F-fluorothymidine PET/CT for primary colorectal cancer and its lymph node metastasis: comparison with ¹⁸F-fluorodeoxyglucose PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Preclinical FLT-PET and FDG-PET imaging of tumor response to the multi-targeted Aurora B kinase inhibitor, TAK-901.
Topics: Animals; Aurora Kinase B; Biological Transport; Biomarkers, Tumor; Carbolines; Colorectal Neoplasms; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; HCT116 Cells; Humans; Mice; Positron-Emission Tomography; Protein Kinase Inhibitors; Sulfones; Treatment Outcome | 2014 |
The enhanced in vivo activity of the combination of a MEK and a PI3K inhibitor correlates with [18F]-FLT PET in human colorectal cancer xenograft tumour-bearing mice.
Topics: Animals; Antiviral Agents; Benzamides; Cell Line, Tumor; Colorectal Neoplasms; Dideoxynucleosides; Diphenylamine; Drug Synergism; Female; Heterografts; Humans; Indazoles; MAP Kinase Kinase Kinases; Mice; Mice, Nude; Neoplasm Transplantation; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Positron-Emission Tomography; Proto-Oncogene Proteins c-akt; Radiography; Sulfonamides | 2013 |
Correlations of (18)F-fluorothymidine uptake with pathological tumour size, Ki-67 and thymidine kinase 1 expressions in primary and metastatic lymph node colorectal cancer foci.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Biopsy; Colonoscopy; Colorectal Neoplasms; Dideoxynucleosides; Female; Fluorine Radioisotopes; Humans; Immunohistochemistry; Ki-67 Antigen; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Thymidine Kinase; Tumor Burden | 2014 |
High-yielding, automated production of 3'-deoxy-3'-[(18)F]fluorothymidine using a modified Bioscan Coincidence FDG reaction module.
Topics: Animals; Colorectal Neoplasms; Dideoxynucleosides; HCT116 Cells; Heterografts; Humans; Mice; Mice, Nude; Positron-Emission Tomography; Quality Control; Radiochemistry; Radiopharmaceuticals | 2015 |
The Synergistic Effect of Selumetinib/Docetaxel Combination Therapy Monitored by [(18)F]FDG/[(18)F]FLT PET and Diffusion-Weighted Magnetic Resonance Imaging in a Colorectal Tumor Xenograft Model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Cell Proliferation; Colorectal Neoplasms; Dideoxynucleosides; Diffusion Magnetic Resonance Imaging; Docetaxel; Drug Synergism; Fluorodeoxyglucose F18; HCT116 Cells; Humans; Immunohistochemistry; Mice; Positron-Emission Tomography; Taxoids; Xenograft Model Antitumor Assays | 2016 |
Evaluation of [
Topics: Adenosine Triphosphate; Animals; Biomarkers, Tumor; Cell Line, Tumor; Colorectal Neoplasms; Dideoxynucleosides; Disease Models, Animal; Female; Immunohistochemistry; Kinetics; Mice, Nude; Reproducibility of Results; Thymidine; Thymidine Kinase | 2017 |
18F-FLT and 18F-FDG PET to measure response to radiotherapy combined with celecoxib in two colorectal xenograft models.
Topics: Animals; Celecoxib; Cell Line, Tumor; Colorectal Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Mice; Positron-Emission Tomography; Pyrazoles; Sulfonamides; Treatment Outcome; Xenograft Model Antitumor Assays | 2009 |
Using dual-tracer PET to predict the biologic behavior of human colorectal cancer.
Topics: Animals; Biological Transport; Blotting, Western; Cell Line, Tumor; Colorectal Neoplasms; Dideoxynucleosides; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Linear Models; Male; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Positron-Emission Tomography; Radioactive Tracers; Tomography, X-Ray Computed | 2009 |
Kinetic filtering of [(18)F]Fluorothymidine in positron emission tomography studies.
Topics: Aged; Algorithms; Breast; Breast Neoplasms; Colorectal Neoplasms; Contrast Media; Dideoxynucleosides; Female; Heart; Humans; Kinetics; Linear Models; Liver; Liver Neoplasms; Nonlinear Dynamics; Positron-Emission Tomography; Signal Processing, Computer-Assisted | 2010 |
Pharmacodynamic evaluation of irinotecan therapy by FDG and FLT PET/CT imaging in a colorectal cancer xenograft model.
Topics: Animals; Camptothecin; Cell Line, Tumor; Colorectal Neoplasms; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Irinotecan; Mice; Mice, SCID; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed; Tumor Burden; Xenograft Model Antitumor Assays | 2012 |
New peptide receptor radionuclide therapy of invasive cancer cells: in vivo studies using 177Lu-DOTA-AE105 targeting uPAR in human colorectal cancer xenografts.
Topics: Animals; Beta Particles; Cell Transformation, Neoplastic; Colorectal Neoplasms; Dideoxynucleosides; Female; Heterocyclic Compounds, 1-Ring; HT29 Cells; Humans; Lutetium; Mice; Molecular Targeted Therapy; Neoplasm Invasiveness; Oligopeptides; Positron-Emission Tomography; Radioisotopes; Receptors, Urokinase Plasminogen Activator; Substrate Specificity | 2012 |
3'-Deoxy-3'-18F-fluorothymidine PET predicts response to (V600E)BRAF-targeted therapy in preclinical models of colorectal cancer.
Topics: Animals; Cell Line, Tumor; Colorectal Neoplasms; Dideoxynucleosides; Drug Resistance, Neoplasm; Fluorine Radioisotopes; Humans; Indoles; MAP Kinase Signaling System; Mice; Mice, Nude; Molecular Targeted Therapy; Mutant Proteins; Positron-Emission Tomography; Predictive Value of Tests; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Radiopharmaceuticals; Sulfonamides; Xenograft Model Antitumor Assays | 2013 |
Assessment of recurrent colorectal cancer following 5-fluorouracil chemotherapy using both 18FDG and 18FLT PET.
Topics: Antineoplastic Agents; Colorectal Neoplasms; Dideoxynucleosides; Fluorodeoxyglucose F18; Fluorouracil; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2004 |